Fny Investment Advisers, LLC Dbv Technologies S.A. Transaction History

Fny Investment Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$1.22 - $1.77 $24,400 - $35,400	-20,000 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$1.39 - $5.58 $27,799 - $111,600	20,000 New	20,000 $32,000
Q4 2020 Jan 19, 2021	SELL	$1.38 - $3.01 $42,702 - $93,141	-30,944 Closed	0 $0
Q3 2020 Oct 09, 2020	BUY	$1.58 - $4.77 $48,891 - $147,602	30,944 New	30,944 $53,000
Q2 2020 Jul 10, 2020	SELL	$3.74 - $6.28 $4,484 - $7,529	-1,199 Closed	0 $0
Q1 2020 Apr 09, 2020	BUY	$2.33 - $12.98 $2,793 - $15,563	1,199 New	1,199 $4,000
Q4 2019 Jan 10, 2020	SELL	$6.75 - $11.15 $28,269 - $46,696	-4,188 Closed	0 $0
Q3 2019 Oct 25, 2019	SELL	$8.57 - $10.72 $71,319 - $89,211	-8,322 Reduced 66.52%	4,188 $36,000
Q2 2019 Jul 24, 2019	BUY	$7.58 - $10.0 $94,825 - $125,100	12,510 New	12,510 $102,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $599M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.